Protagonist Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Protagonist Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Protagonist Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Protagonist Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $24M | 363k | 66.43 |
| 2025-06-30 | $21M | 388k | 55.27 |
| 2025-03-31 | $18M | 377k | 48.36 |
| 2024-12-31 | $15M | 391k | 38.60 |
| 2024-09-30 | $16M | 356k | 45.00 |
| 2024-06-30 | $7.1M | 204k | 34.65 |
| 2024-03-31 | $5.4M | 187k | 28.93 |
| 2023-12-31 | $4.7M | 203k | 22.93 |
| 2023-09-30 | $3.4M | 201k | 16.68 |
| 2023-06-30 | $5.5M | 200k | 27.62 |
| 2023-03-31 | $3.9M | 169k | 23.00 |
| 2022-12-31 | $1.8M | 164k | 10.91 |
| 2022-09-30 | $0 | 158k | 0.00 |
| 2022-06-30 | $1.1M | 142k | 7.91 |
| 2022-03-31 | $3.3M | 140k | 23.68 |
| 2021-12-31 | $4.5M | 139k | 32.26 |
| 2021-09-30 | $2.3M | 131k | 17.73 |
| 2021-06-30 | $6.6M | 146k | 44.88 |
| 2021-03-31 | $3.5M | 134k | 25.90 |
| 2020-12-31 | $2.6M | 129k | 20.16 |
| 2020-09-30 | $1.8M | 95k | 19.54 |
| 2020-06-30 | $1.8M | 101k | 17.67 |
| 2020-03-31 | $591k | 84k | 7.07 |
| 2019-12-31 | $588k | 84k | 7.04 |
| 2019-09-30 | $930k | 77k | 12.01 |
| 2019-06-30 | $1.3M | 104k | 12.12 |
| 2019-03-31 | $792k | 63k | 12.56 |
| 2018-12-31 | $426k | 63k | 6.73 |
| 2018-09-30 | $651k | 63k | 10.29 |
| 2018-06-30 | $426k | 63k | 6.73 |
| 2018-03-31 | $430k | 50k | 8.60 |
| 2017-12-31 | $925k | 45k | 20.80 |
| 2017-06-30 | $314k | 28k | 11.36 |
| 2017-03-31 | $332k | 26k | 12.69 |
| 2016-12-31 | $501k | 23k | 22.06 |
| 2016-09-30 | $305k | 14k | 21.47 |